Mrs. Hanri Van Zijl

Hanri Van Zijl is a researcher in hematological oncology with a focus on the molecular and clinical characterization of acute myeloid leukaemia within the South African healthcare context. Their work engages with evolving international classification frameworks, aligning local clinical realities with global diagnostic standards.

Research by Van Zijl centers on the genetic landscape of AML, emphasizing disease heterogeneity and its implications for diagnosis and treatment. This includes attention to how resource-constrained public health systems can integrate advanced genomic insights into routine care, contributing to more precise and contextually relevant cancer management.

Based on limited available publications, the work reflects a commitment to bridging global oncology research with regional clinical needs. Contributions highlight the importance of localized data in refining classification systems and improving patient outcomes in underrepresented populations.